0

An Autoinhibitory Tyrosine Motif in the Cell-Cycle-Regulated Nek7 Kinase Is Released Through Binding of Nek9

Mark W Richards, Laura O'Regan, Corine Mas-Droux, Joelle M Y Blot, Jack Cheung, Swen Hoelder, Andrew M Fry, Richard Bayliss

Mol Cell. 2009 Nov 25;36(4):560-70.

PMID: 19941817

Abstract:

Mitosis is controlled by multiple protein kinases, many of which are abnormally expressed in human cancers. Nek2, Nek6, Nek7, and Nek9 are NIMA-related kinases essential for proper mitotic progression. We determined the atomic structure of Nek7 and discovered an autoinhibited conformation that suggests a regulatory mechanism not previously described in kinases. Additionally, Nek2 adopts the same conformation when bound to a drug-like molecule. In both structures, a tyrosine side chain points into the active site, interacts with the activation loop, and blocks the alphaC helix. Tyrosine mutants of Nek7 and the related kinase Nek6 are constitutively active. The activity of Nek6 and Nek7, but not the tyrosine mutant, is increased by interaction with the Nek9 noncatalytic C-terminal domain, suggesting a mechanism in which the tyrosine is released from its autoinhibitory position. The autoinhibitory conformation is common to three Neks and provides a potential target for selective kinase inhibitors.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR42411904 Nek7, Active human Nek7, Active human Price
qrcode